Plus Therapeutics Inc. (PSTV) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Plus Therapeutics Inc.

NASDAQ: PSTV · Real-Time Price · USD
0.49
-0.02 (-3.01%)
At close: Aug 27, 2025, 3:59 PM

Plus Therapeutics Revenue

Plus Therapeutics reported an annual revenue of $5.82M, reflecting a 18.54% growth. For the quarter ending June 30, 2025, Plus Therapeutics generated $1.39M in revenue.
Revenue (ttm)
5.82M
Revenue Growth
18.54%
Price / Sales Ratio
1.31
Revenue / Employee
277.33K
Employees
21
Market Cap
29.94M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 5.82M +18.54%
Dec 31, 2023 4.91M +2093.30%
Dec 31, 2022 224K +Infinity%
Dec 31, 2021 0 -100.00%
Dec 31, 2020 303K -95.67%
Dec 31, 2019 7M +134.60%
Dec 31, 2018 2.98M -53.47%
Dec 31, 2017 6.41M -43.66%
Dec 31, 2016 11.38M -2.39%
Dec 31, 2015 11.66M +53.45%
Dec 31, 2014 7.6M -37.70%
Dec 31, 2013 12.2M -15.90%
Dec 31, 2012 14.5M +45.07%
Dec 31, 2011 10M -5.94%
Dec 31, 2010 10.63M -27.85%
Dec 31, 2009 14.73M +114.94%
Dec 31, 2008 6.85M +13.29%
Dec 31, 2007 6.05M -23.69%
Dec 31, 2006 7.93M +32.01%
Dec 31, 2005 6M -11.92%
Dec 31, 2004 6.82M -51.60%
Dec 31, 2003 14.09M +53.70%
Dec 31, 2002 9.17M +62.29%
Dec 31, 2001 5.65M -9.65%
Dec 31, 2000 6.25M +313.15%
Dec 31, 1999 1.51M +Infinity%
Dec 31, 1998 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.